Xiaowei Zhang

Xiaowei Zhang

Auto-generated profile, based on publicly available information

Xiaowei Zhang

School of Computer Science and Information Engineering, Hefei University of Technology, Hefei, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022
Verified
Conference Paper
Open access
HWHui Wang
Hui Wang
WZWei Xiao Zhang
Wei Xiao Zhang
YYYu Zhen Yang
Yu Zhen Yang
LHLan Yan Hu
Lan Yan Hu
DHDonghui Hu
Donghui Hu
The application of sharding is of significant help to improve the scalability of blockchain. The existing sharding system puts too much emphasis on the isolation of zones, which to a certain extent increases the isolation between zones and brings additional load. In this paper, we propose a sharding approach based on the Minimum Cut Method (MC sharding), which is a complete sharding. The number of connections inside each zone is essentially the same. The evaluation results show that MC sharding is more secure and scalable than the existing system, with 1.5 times higher transaction throughput and significantly lower stale block rate in a blockchain system with 4000 nodes and 6 shards. Most importantly, MC sharding can be applied in practice very quickly because it does not change the main procedure of Bitcoin and the block data structure.

20 May 2019 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
XLXin Liu
Xin Liu
JCJun Cao
Jun Cao
YMYanchun Meng
Yanchun Meng
XZXiaowei Zhang
Xiaowei Zhang
YXYu Xu
Yu Xu
ZLZhiguo Luo
Zhiguo Luo
E21019 Background: There is no standard treatment for patients with advanced mucosal melanoma (AMM). Recombinant human endostatin (Endostar) combined with chemotherapy had been showed to improve the efficacy of advanced melanoma. This real world study was aimed to observe the efficacy and safety of endostar continuous intravenous infusion (Civ) combined with chemotherapy in patients with AMM. Methods: 23 patients with AMM treated with endostar plus dacarbazine or temozolomide plus cisplatin between April 2017 and December 2018 were collected. Endostar was given 105mg/m2 Civ168h (unlike the usual use of 7.5mg/m2/d d1-14) . 5 patients with local advanced disease received concurrent radiotherapy. Results: There were 11 males (48%) and 12 females (52%), with a median age of 58 years (30-72 years). Primary lesions were located in the nasal cavity and paranasal sinuses in 9 cases (39%), anorectum in 9 cases (39%), vagina in 3 cases (13%), esophagus in 1 case (4%), and choroid in 1 case (4%). There were 7 patients with local advanced disease and 16 patients with metastatic disease. 1 patient received prior anti-PD1 therapy, 1 patient received prior chemotherapy, the other 19 patients received no prior systemic therapy. A total of 21 patients underwent gene detection, there were 2 patients (10%) with BRAF mutation (one with V600E mutation, one with G606E mutation), 7 patients (33%) with NRAS mutation (3 with exon 2 mutation, 4 with exon 3 mutation), and 1 patient (5%) with KIT exon 11 mutation. Overall, 4 patients (13%) had CR, 4 patients (22%) had PR, 10 patients had SD (43%), and 5 patients (22%) had PD, resulting in a RR of 35% and a DCR of 78%. The 4 patients with CR were with localized disease and received concurrent radiotherapy. The RR were 44%, 33%, 33%, 0% and 0%, and the DCR were 100%, 67%, 67%, 0%, and 100% in patients with melanoma of the nasal cavity, anorectum, vagina, esophagus and choroid respectively. The median PFS was 7.5 months (95% CI: 1.0-14.0months). The median OS was 14.7 months (95% CI: 5.0-24.4months). Grade III/IV adverse events were leucopenia (13%), thrombocytopenia (13%), anemia (4%), nausea and vomiting (4%), elevated transaminase (4%), nasal hemorrhage (4%) and intestinal obstruction (4%). Conclusions: Endostar combined with chemotherapy is effective and safe in the treatment of AMM, especially for patients with melanoma of the nasal cavity and paranasal sinuses. For mucosal melanoma patients with local advanced disease, concurrent chemoradiotherapy may be a good choice. It deserves further study.

26 August 2024 in IEEE Transactions on Network and Service Management
Verified
Journal Article
Closed access
HWHui Wang
Hui Wang
ZYZhenyu Yang
Zhenyu Yang
MLMing Li
Ming Li
XZXiaowei Zhang
Xiaowei Zhang
YHYanlan Hu
Yanlan Hu
DHDonghui Hu
Donghui Hu
As the origin of blockchains, the Nakamoto Consensus protocol is the primary protocol for many public blockchains (e.g., Bitcoin) used in cryptocurrencies. Blockchains need to be decentralized as a core feature, yet it is difficult to strike a balance between scalability and security. Many approaches to improving blockchain scalability often result in diminished security or compromise the decentralized nature of the system. Inspired by network science, especially the epidemic model, we try to solve this problem by mapping the propagation of transactions and blocks as two interacting epidemics, called the CoSIS model. We extend the transaction propagation process to increase the efficiency of block propagation, which reduces the number of unknown transactions. The reduction of the block propagation latency ultimately increases the blockchain throughput. The theory of complex networks is employed to offer an optimal boundary condition. Finally, the node scores are stored in the chain, so that it also provides a new incentive approach. Our experiments show that CoSIS accelerates blocks!/ propagation and TPS is raised by 20% ~ 33% on average. At the same time, the system security can be significantly improved, as an orphaned block rate is close to zero in better cases. CoSIS enhances the scalability and security of the blockchain while ensuring that all changes do not compromise the decentralized nature of the blockchain.